Both FA- and mPEG-conjugated chitosan nanoparticles for targeted cellular uptake and enhanced tumor tissue distribution

Nanoscale Research Letters

Volumn 6, Issue , 2011, Pages 1-11

  Hou, Zhenqing ^a   Zhan, Chuanming ^a   Jiang, Qiwei ^a   Hu, Quan ^a   Li, Le ^a   Chang, Di ^a   Yang, Xiangrui ^a   Wang, Yixiao ^a   Li, Yang ^a   Ye, Shefang ^a   Xie, Liya ^a   Yi, Yunfeng ^a   Zhang, Qiqing ^a,b  

^a XIAMEN UNIVERSITY   (China)

^b Tianjin Key Laboratory of Biomedical Materials   (China)

Author keywords

Chitosan; Drug delivery; Mitomycin c; Nanoparticles

Indexed keywords

ANIMAL EXPERIMENTS; ANTI-CANCER DRUG DELIVERY; AVERAGE DIAMETER; BIPHASIC; BURST RELEASE; CANCEROUS CELLS; CELLULAR UPTAKE; CHEMICAL CROSS-LINKING; CHITOSAN NANOPARTICLES; CONFOCAL SCANNING; DRUG DELIVERY SYSTEM; DRUG RELEASE; FOLIC ACIDS; HELA CELL; HUMAN ADENOCARCINOMA; IN-VIVO; INTRACELLULAR UPTAKE; MITOMYCIN C; MODEL DRUGS; NUDE MICE; TUMOR TISSUES;

CELLS; CHITOSAN; COAGULATION; CROSSLINKING; DRUG DELIVERY; ETHYLENE; ETHYLENE GLYCOL; FUNCTIONAL GROUPS; GELATION; NANOPARTICLES; ORGANIC ACIDS; TUMORS;

MOTION PICTURE EXPERTS GROUP STANDARDS;

ANIMALIA; MUS MUSCULUS;

EID: 84862968902     PISSN: 19317573     EISSN: 1556276X     Source Type: Journal    
DOI: 10.1186/1556-276X-6-563     Document Type: Article

References (34)

1. Matsumura Y, Maeda H: A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 1986, 46:6387.
2. Duncan R: Polymer conjugates for tumour targeting and intracytoplasmic delivery: the EPR effect as a common gateway. Pharm Sci Technol Today 1999, 2:441.
3. Lee KY, Kim JH, Kwon IC, Jeong SY: Self-aggregates of deoxycholic acidmodified chitosan as a novel carrier of adriamycin. Colloid Polym Sci 2000, 278:1216.
4. Ruel-Gariepy E, Leclair G, Hildgen P, Gupta A, Leroux JC: Thermosensitive chitosan-based hydrogel containing liposomes for the delivery of hydrophilic molecules. J Control Release 2002, 82:373.
5. Hirano S: Chitin and chitosan as novel biotechnological materials. Polym Int 1999, 48:732.
6. Molinaro G, Leroux J, Damas J, Adam A: Biocompatibility of thermosensitive chitosan-based hydrogels: an in vivo experimental approach to injectable biomaterials. Biomaterials 2002, 23:2717.
7. Park JH, Cho YW, Chung H, Kwon IC, Jeong SY: Synthesis and characterization of sugar-bearing chitosan derivatives: aqueous solubility and biodegradability. Biomacromolecules 2003, 4:1087.
8. Dufes C, Schätzlein AG, Tetley L, Gray AI, Watson DG, Olivier JC, Couet W, Uchegbu IF: Niosomes and polymeric chitosan based vesicles bearing transferrin and glucose ligands for drug targeting. Pharm Res 2000, 17:1250.
9. Hejazi R, Amiji M: Chitosan-based gastrointestinal delivery systems. J Control Release 2003, 89:151.
10. Berthold A, Cremer K, Kreuter J: Preparation and characterization of chitosan microspheres as drug carrier for prednisolone sodium phosphate as model for antiinflammatory drugs. J Control Release 1996, 39:17.
11. Tian XX, Groves MJ: Formulation and biological activity of antineoplastic proteoglycans derived from mycobacterium vaccae in chitosan nanoparticles. J Pharm Pharmacol 1999, 51:151.
12. Ohya Y, Shiratani M, Kobayashi H, Ouchi T: Release behavior of 5- fluorouracil from chitosan-gel nanospheres immobilizing 5-fluorouracil coated with polysaccharides and their cell specific cytotoxicity. J Macromol Sci Pure Appl Chem 1994, 31:629.
13. Bodmeier R, Oh KH, Pramar Y: Preparation and evaluation of drugcontaining chitosan beads. Drug Dev Ind Pharm 1987, 15:1475.
14. Tokumitsu H, Ichikawa H, Fukumori Y: Chitosan-gadopentetic acid complex nanoparticles for gadolinium neutron-capture therapy of cancer: preparation by emulsion-droplet coalescence technique and characterization. Iran J Pharmaceut Res 1999, 16:1830.
15. Thanoo BC, Sunny MC, Jayakrishnan A: Cross-linked chitosan microspheres: Preparation and evaluation as a matrix for controlled release of pharmaceuticals. J Pharm Pharmcol 1992, 44:283.
16. Gupta KC, Jabrail FH: Controlled-release formulations for hydroxy urea and rifampicin using polyphosphate-anion-crosslinked chitosan microspheres. J Appl Polym Sci 2007, 104:1942.
17. Owens DE, Peppas NA: Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm 2006, 307:93.
18. Veronese FM, Pasut G: PEGylation, successful approach to drug delivery. Drug Discov Today 2005, 10:1451.
19. Park JH, Lee S, Kim JH, Park K, Kim K, Kwon IC: Polymeric nanomedicine for cancer therapy. Prog Polym Sci 2008, 33:113.
20. Sheng Y, Liu CS, Yuan Y, Tao XY, Yang F, Shan XQ, Zhou HJ, Xu F: Longcirculating polymeric nanoparticles bearing a combinatorial coating of PEG and water-soluble chitosan. Biomaterials 2009, 30:2340.
21. Sun C, Sze R, Zhang M: Folic acid-PEG conjugated superparamagnetic nanoparticles for targeted cellular uptake and detection by MRI. J Biomed Mater Res 2006, 78:550.
22. Kim SH, Jeong JH, Chun KW, Park TG: Target-specific cellular uptake of PLGA nanoparticles coated with poly(L-lysine)-poly(ethylene glycol)- folate conjugate. Langmuir 2005, 21:8852.
23. Sudimack J, Lee RJ: Drug targeting via the folate receptor. Adv Drug Deliv Rev 2000, 41:147.
24. Goren D, Horowitz AT, Tzemach D, Tarshish M, Zalipsky S, Gabizon A: Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump. Clin Cancer Res 2000, 6:1949.
25. Leamon CP, Reddy JA: Folate-targeted chemotherapy. Adv Drug Delivery Rev 2004, 56:1127.
26. Shoepf U, Marecos E, Melder R, Jain R, Weissleder R: Intracellular magnetic labeling of lymphocytes for in vivo trafficking studies. Bio Techniques 1998, 24:642.
27. Weissleder R, Cheng HC, Bogdanova A: Magnetically labeled cells can be detected by MR imaging. J Magn Reson Imaging 1997, 7:258.
28. Lee R, Kim PH, Choi JW, Oh-Joon K, Kim K, Kim D, Yun CO, Yoo KH: Capacitance-based real time monitoring of receptor-mediated endocytosis. Biosensors and Bioelectronics 2010, 25:1325.
29. Alexis F, Pridgen E, Molnar LK, Farokhzad OC: Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm 2008, 5:505.
30. Gao H, Shi W, Freund LB: Mechanics of receptor-mediated endocytosis. Proc Natl Acad Sci USA 2005, 102:9469.
31. Park JH, Lee S, Kim JH, Park K, Kim K, Kwon IC: Polymeric nanomedicine for cancer therapy. Pro Polym Sci 2008, 33:113.
32. Shi B, Fang C, Pei YY: Stealth PEG-PHDCA niosomes: effects of chain length of PEG and particle size on niosome surface properties, in vitro drug release, phagocytic uptake, in vivo pharmacokinetics and antitumor activity. J Pharm Sci 2006, 95:1873.
33. Jiang YY, Tang GT, Hong MH, Zhu SJ, Fang C, Shi B, Pei YY: Active tumortargeted delivery of PEG-protein via transferrin-transferrin-receptor system. J Drug Target 2007, 15:672.
34. Pirollo KF, Chang EH: Does a targeting ligand influence nanoparticle tumor localization or uptake? Trends Biotechnol 2008, 26:552.